宫颈癌开腹与机器人根治性子宫切除术的生存结局:我们的外科病理学审视
本机构回顾性研究纳入2000至2017年接受开腹或机器人根治性子宫切除术的临床IA2-IIA期宫颈癌患者333例(开腹181例,机器人152例),采用逆倾向评分加权调整选择偏倚。机器人组5年无进展生存率79.0%低于开腹组90.5%(HR 2.37,95%CI 1.40-4.02),5年总生存率85.8%低于开腹组95.3%(HR 3.17,95%CI 1.76-5.70),而病理测量的宫旁宽度两组相似。
要点
- 机器人根治性子宫切除术组5年无进展生存率79.0%,低于开腹组的90.5%(HR 2.37,95%CI 1.40-4.02)。
- 机器人组5年总生存率85.8%,低于开腹组的95.3%(HR 3.17,95%CI 1.76-5.70)。
- 病理测量的宫旁宽度两组相似(开腹2.5 cm vs 机器人2.4 cm,p=0.99)。
核心结论
- 接受机器人根治性子宫切除术的患者无进展生存和总生存均劣于开腹手术。
- 根据病理测量的手术根治性在两种入路之间相似。
研究设计与样本
- 本机构回顾性研究,纳入2000至2017年临床IA2-IIA期(FIGO 2009)鳞状细胞癌、腺癌及腺鳞癌宫颈癌患者。
- 共333例患者,其中开腹181例,机器人152例。
- 从病理切片重新测量宫旁宽度和阴道长度。
- 采用逆倾向评分加权模型调整选择偏倚。
主要发现
- 开腹组中位随访130个月,机器人组53个月。
- 开腹组复发31例(17.1%),机器人组复发21例(13.8%)。
- 机器人组与开腹组5年无进展生存率分别为79.0%和90.5%(HR 2.37,95%CI 1.40-4.02)。
- 机器人组与开腹组5年总生存率分别为85.8%和95.3%(HR 3.17,95%CI 1.76-5.70)。
- 开腹组与机器人组平均宫旁宽度相似(2.5 vs 2.4 cm,p=0.99)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the survival outcomes and surgical radicality between women who underwent open versus robotic radical hysterectomy (RH) for early cervical cancer. METHODS: In this institutional retrospective study, patients with clinical stage IA2- IIA (FIGO 2009) squamous cell, adenocarcinoma and adenosquamous carcinoma of the cervix who underwent either open or robotic RH between 2000 and 2017 were identified. Parametrial width and vaginal length were re-measured from pathology slides. An inverse propensity score weighting model was used to adjust selection bias. RESULTS: A total of 333 patients were included (181 open, 152 robotic). The median follow-up time was 130 months for the open group and 53 months for the robotic group. There were 31 (17.1%) recurrences in the open and 21 (13.8%) in the robotic group. The 5-year progression-free survival (PFS) for the robotic and open group were 79.0% and 90.5%, respectively (HR 2.37, 95% CI 1.40-4.02). Five-year overall survival (OS) were 85.8% and 95.3%, respectively (HR 3.17, 95% CI 1.76-5.70). The mean parametrial width was similar between the open and robotic groups (2.5 vs 2.4 cm, p = 0.99). Unique recurrences (38.1%, 8/21) were noted in the robotic group: 2 port-site, 4 peritoneal, and 2 carcinomatosis. The time to vaginal recurrence was shorter in the robotic group than the open group (p = 0.001). CONCLUSION: Patients who underwent robotic RH had inferior PFS and OS compared to open surgery. Surgical radicality according to pathology measurements was similar between the two approaches.
引用
- Yang J, Mead-Harvey C, Polen-De C, et al. Survival outcomes in patients with cervical cancer treated with open versus robotic radical hysterectomy: Our surgical pathology interrogation. Gynecol Oncol. 2020. PMID: 32893029. doi:10.1016/j.ygyno.2020.08.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。